NCT01518998
A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension
Phase: Phase 2
Role: Collaborator
Start: Aug 31, 2011
Completion: Nov 30, 2013